New Insights Into Optimal Timing of Hepatitis C Virus Treatment for Dialysis Patients Waitlisted for Kidney Transplant

Direct-acting antiviral therapy for hepatitis C virus (HCV) infection has introduced a dilemma for kidney transplantation in HCV-infected patients: Pursue an HCV cure first, or accept an HCV-infected donor organ and receive treatment afterward? In their article, Eckman and colleagues report a decision model that concludes that the second option is superior. The editorialists believe that this information should lead to better care for some patients and wider use of HCV-infected kidneys, but regional variation in the availability of HCV-infected organs and patient preferences will sometimes make treatment first a reasonable choice.

https://ift.tt/2L6U1FO